Patent Number: 6,333,358

Title: Aryloxyaniline derivatives

Abstract: An aryloxyaniline derivative represented by the formula:##STR1##wherein Ar.sup.1 and Ar.sup.2 are each a substituted or unsubstitutedphenyl group, pyridyl group or naphthyl group, R.sup.1 is a hydrogen atom,an alkyl group, etc., X.sup.1 is a hydrogen atom, an alkyl group, etc.,y.sup.1 is a branched or unbranched alkylene group having 1 to 6 carbonatoms or a single bond; or a pharmaceutically acceptable salt thereof canprovide medicines having a high affinity for MDR, and therefore,exhibiting a therapeutic or preventive effect on anxiety, related diseasesthereto, depression, etc.

Inventors: Nakazato; Atsuro (Tokyo, JP), Okubo; Taketoshi (Tokyo, JP), Nakamura; Toshio (Tokyo, JP), Chaki; Shigeyuki (Tokyo, JP), Tomisawa; Kazuyuki (Tokyo, JP), Nagamine; Masashi (Osaka, JP), Yamamoto; Kenji (Osaka, JP), Harada; Koichiro (Osaka, JP), Yoshida; Masanori (Osaka, JP)

Assignee:

International Classification: C07C 311/46 (20060101); C07C 235/78 (20060101); C07C 237/30 (20060101); C07C 323/00 (20060101); C07C 323/60 (20060101); C07C 235/38 (20060101); C07C 233/25 (20060101); C07C 311/00 (20060101); C07C 233/54 (20060101); C07C 233/00 (20060101); C07C 311/27 (20060101); C07C 247/00 (20060101); C07C 311/29 (20060101); C07C 235/00 (20060101); C07C 247/10 (20060101); C07C 233/33 (20060101); C07C 275/32 (20060101); C07C 275/00 (20060101); C07C 323/41 (20060101); C07C 323/20 (20060101); C07C 237/00 (20060101); C07D 213/40 (20060101); C07D 213/00 (20060101); C07D 213/68 (20060101); C07D 213/65 (20060101); C07D 213/643 (20060101); A61K 031/135 (); A61K 031/165 ()

Expiration Date: 12/25/2014